Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-May-24 5:50 PM View:  | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 01-May-24 | Planned Option Sale | 18,168 | $51.33 | $932,557.00 | (67%) 27.11K to 8.94K | |
| 03-May-24 5:50 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 01-May-24 | Option Exercise | 18,168 | $6.28 | $114,095.00 | 203% 8.94K to 27.11K | |
| 18-Apr-24 4:01 PM View: | Ware Olivia C Director | Arcellx, Inc. (ACLX) | 16-Apr-24 | Option Exercise | 9,402 | $7.61 | $71,549.20 | 100% 0 to 9.4K | |
| 18-Apr-24 4:01 PM View: | Ware Olivia C Director | Arcellx, Inc. (ACLX) | 16-Apr-24 | Planned Option Sale | 9,402 | $55.55 | $522,260.00 | (100%) 9.4K to 0 | |
| 03-Apr-24 4:44 PM View: | Elghandour Rami See Remarks Director | Arcellx, Inc. (ACLX) | 01-Apr-24 | Private Sale (Planned) | 23,086 | $67.09 | $1,548,890.00 | (25%) 92.34K to 69.25K | |
| 26-Mar-24 8:52 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 26-Mar-24 | Option Exercise | 5,450 | $6.28 | $34,226.00 | 61% 8.94K to 14.39K | |
| 26-Mar-24 8:52 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 26-Mar-24 | Sale (Planned) | 5,450 | $69.11 | $376,648.00 | (38%) 14.39K to 8.94K | |
| 26-Mar-24 8:52 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 22-Mar-24 | Option Exercise | 20,000 | $6.28 | $125,600.00 | 66% 30.3K to 50.3K | |
| 26-Mar-24 8:52 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 22-Mar-24 | Sale (Planned) | 15,915 | $70.18 | $1,116,940.00 | (64%) 24.85K to 8.94K | |
| 26-Mar-24 8:52 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 22-Mar-24 | Planned Option Sale | 25,450 | $70.18 | $1,786,120.00 | (51%) 50.3K to 24.85K | |
| 25-Mar-24 5:30 PM View: | Carroll Jill Director | Arcellx, Inc. (ACLX) | 21-Mar-24 | Private Sale | 504,263 | $70.55 | $35,575,800.00 | (25%) 1.98M to 1.48M | |
| 18-Mar-24 8:49 PM View: | Gilson Michelle Chief Financial Officer | Arcellx, Inc. (ACLX) | 18-Mar-24 | Private Sale (Planned) | 6,825 | $69.34 | $473,255.00 | (42%) 16.31K to 9.48K | |
| 18-Mar-24 6:38 PM View: | Ware Olivia C Director | Arcellx, Inc. (ACLX) | 15-Mar-24 | Planned Option Sale | 9,000 | $70.40 | $633,582.00 | (100%) 9.0K to 0 | |
| 18-Mar-24 6:38 PM View: | Ware Olivia C Director | Arcellx, Inc. (ACLX) | 15-Mar-24 | Option Exercise | 9,000 | $7.61 | $68,490.00 | 100% 0 to 9.0K | |
| 12-Feb-24 7:46 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 12-Feb-24 | Sale | 2,967 | $64.46 | $191,251.00 | (9%) 33.27K to 30.3K | |
| 12-Feb-24 7:43 PM View: | Elghandour Rami See Remarks Director | Arcellx, Inc. (ACLX) | 12-Feb-24 | Sale | 11,169 | $64.46 | $719,948.00 | (11%) 103.51K to 92.34K | |
| 12-Feb-24 7:46 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 09-Feb-24 | Sale | 3,688 | $63.40 | $233,811.00 | (10%) 36.96K to 33.27K | |
| 12-Feb-24 7:43 PM View: | Elghandour Rami See Remarks Director | Arcellx, Inc. (ACLX) | 09-Feb-24 | Sale | 13,886 | $63.40 | $880,340.00 | (12%) 117.39K to 103.51K | |
| 12-Feb-24 7:43 PM View: | Elghandour Rami See Remarks Director | Arcellx, Inc. (ACLX) | 08-Feb-24 | Private Sale | 13,010 | $62.29 | $810,451.00 | (10%) 130.4K to 117.39K | |
| 12-Feb-24 7:46 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 08-Feb-24 | Private Sale | 3,456 | $62.29 | $215,290.00 | (9%) 40.41K to 36.96K | |
| 09-Feb-24 4:05 PM View: | Elghandour Rami See Remarks Director | Arcellx, Inc. (ACLX) | 07-Feb-24 | Option Exercise | 70,211 | -- | -- | 117% 60.19K to 130.4K | |
| 09-Feb-24 4:08 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 07-Feb-24 | Option Exercise | 22,555 | -- | -- | 126% 17.86K to 40.41K | |
| 08-Jan-24 4:02 PM View: | Elghandour Rami See Remarks Director | Arcellx, Inc. (ACLX) | 04-Jan-24 | Private Sale | 29,073 | $55.27 | $1,606,800.00 | (33%) 89.27K to 60.19K | |
| 08-Jan-24 4:06 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 04-Jan-24 | Private Sale | 7,598 | $55.27 | $419,926.00 | (30%) 25.46K to 17.86K | |
| 08-Jan-24 4:04 PM View: | Gilson Michelle Chief Financial Officer | Arcellx, Inc. (ACLX) | 04-Jan-24 | Private Sale | 8,514 | $55.27 | $470,551.00 | (34%) 24.82K to 16.31K | |
| 04-Jan-24 7:29 PM View: | Elghandour Rami See Remarks Director | Arcellx, Inc. (ACLX) | 03-Jan-24 | Option Exercise | 53,097 | -- | -- | 147% 36.17K to 89.27K | |
| 04-Jan-24 7:32 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 03-Jan-24 | Option Exercise | 16,519 | -- | -- | 185% 8.94K to 25.46K | |
| 19-Dec-23 4:43 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 18-Dec-23 | Option Sale | 120,000 | $50.17 | $6,020,280.00 | (94%) 127.8K to 7.79K | |
| 19-Dec-23 4:43 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 18-Dec-23 | Option Exercise | 120,000 | $6.28 | $753,600.00 | 1539% 7.79K to 127.8K | |
| 18-Dec-23 4:47 PM View: | Carroll Jill Director | Arcellx, Inc. (ACLX) | 14-Dec-23 | Private Sale | 504,263 | $49.13 | $24,774,400.00 | (20%) 2.49M to 1.98M | |
| 07-Aug-23 4:51 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 04-Aug-23 | Option Exercise | 3,000 | $15.00 | $45,000.00 | 38% 7.79K to 10.79K | |
| 07-Aug-23 4:51 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 04-Aug-23 | Planned Option Sale | 3,000 | $35.38 | $106,133.00 | (28%) 10.79K to 7.79K | |
| 05-Jul-23 10:00 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 03-Jul-23 | Option Exercise | 3,000 | $15.00 | $45,000.00 | 38% 7.79K to 10.79K | |
| 05-Jul-23 10:00 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 03-Jul-23 | Planned Option Sale | 3,000 | $31.75 | $95,246.10 | (28%) 10.79K to 7.79K | |
| 02-Jun-23 4:56 PM View: | Carroll Jill Director | Arcellx, Inc. (ACLX) | 01-Jun-23 | Sale | 25,556 | $44.35 | $1,133,320.00 | (1%) 2.51M to 2.49M | |
| 05-Jun-23 4:46 PM View: | Behbahani Ali Director | Arcellx, Inc. (ACLX) | 01-Jun-23 | Acquisition (other) | 28 | -- | -- | 7% 0.4K to 0.42K | |
| 05-Jun-23 4:46 PM View: | Behbahani Ali Director | Arcellx, Inc. (ACLX) | 01-Jun-23 | Acquisition (other) | 113 | -- | -- | 40% 0.28K to 0.4K | |
| 02-Jun-23 4:56 PM View: | Carroll Jill Director | Arcellx, Inc. (ACLX) | 31-May-23 | Private Sale | 315,164 | $41.50 | $13,079,300.00 | (11%) 2.83M to 2.51M | |
| 02-Jun-23 5:10 PM View: | Elghandour Rami See Remarks Director | Arcellx, Inc. (ACLX) | 31-May-23 | Private Sale | 2,600 | $44.27 | $115,099.00 | (7%) 38.77K to 36.17K | |
| 25-May-23 8:21 PM View: | Gilson Michelle Chief Financial Officer | Arcellx, Inc. (ACLX) | 25-May-23 | Option Sale | 6,000 | $42.77 | $256,616.00 | (39%) 15.48K to 9.48K | |
| 25-May-23 8:21 PM View: | Gilson Michelle Chief Financial Officer | Arcellx, Inc. (ACLX) | 24-May-23 | Option Sale | 8,704 | $42.46 | $369,534.00 | (36%) 24.19K to 15.48K | |
| 25-May-23 8:21 PM View: | Gilson Michelle Chief Financial Officer | Arcellx, Inc. (ACLX) | 23-May-23 | Option Exercise | 22,428 | -- | -- | 1274% 1.76K to 24.19K | |
| 15-May-23 6:18 PM View: | Carroll Jill Director | Arcellx, Inc. (ACLX) | 11-May-23 | Private Sale | 638,417 | $45.01 | $28,736,200.00 | (18%) 3.47M to 2.83M | |
| 15-May-23 6:16 PM View: | Sr One Capital Management, ... 10% Owner | Arcellx, Inc. (ACLX) | 11-May-23 | Private Sale | 1,012,830 | $45.01 | $45,589,300.00 | (18%) 5.5M to 4.49M | |
| 11-May-23 4:10 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 10-May-23 | Sale (Planned) | 2,197 | $45.18 | $99,265.70 | (22%) 9.99K to 7.79K | |
| 11-May-23 4:10 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 09-May-23 | Private Sale (Planned) | 500 | $45.00 | $22,500.00 | (5%) 10.49K to 9.99K | |
| 08-May-23 6:50 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 05-May-23 | Private Sale (Planned) | 1,200 | $45.00 | $54,002.00 | (10%) 11.69K to 10.49K | |
| 05-May-23 4:10 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 03-May-23 | Option Exercise | 3,000 | $15.00 | $45,000.00 | 26% 11.69K to 14.69K | |
| 05-May-23 4:10 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 03-May-23 | Planned Option Sale | 3,000 | $43.44 | $130,329.00 | (20%) 14.69K to 11.69K | |
| 26-Apr-23 4:11 PM View: | Heery Christopher Chief Medical Officer | Arcellx, Inc. (ACLX) | 24-Apr-23 | Planned Option Sale | 20,000 | $40.00 | $800,068.00 | (63%) 31.69K to 11.69K |
